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Abstract: 
Introduction: Mycobacterium tuberculosis is a Non-moving bacillus that lacks spore and acid fast. This 
bacterium produces a unique compound called mycolic acid in its wall affecting the performance of the wall. 
The vascular wall of this bacterium offers unique properties such as hydrophobicity, having acid fast, acid 
resistance, openness, dryness and many antibiotics. 
Methods: In this review article, the databases Medline, Cochrane, Science Direct, and Google Scholar were 
thoroughly searched to identify the studies investigating Tuberculosis and BCG vaccine. In this review, the 
papers published until early January 2017 that was conducted to study the Tuberculosis and BCG vaccine were 
selected. In searching for the articles, those English papers were selected that had investigated Tuberculosis 
and BCG vaccine and its complications. 
Findings : The awareness of this dangerous complication, its underlying causes, and the clinical features of this 
disease, and paying due attention to this complication while examining infants who are taken to the doctor for 
the magnitude of lymph nodes adjacent to the inoculation region is of great importance for all doctors specially 
pediatricians.  
Conclusion and Discussion: For this reason, the doctors need to be aware of the dangerous, yet less prevalent, 
complications of BCG vaccine. When they are examining the infants, they need to conduct complete examination 
and examine cervical and adjacent lymph node. They should also give due attention to hepatosplenomegaly, 
since when there are cases of hepatosplenomegaly, the patient needs to undergo further examination for the 
BCG infection. 
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Mycobacterium tuberculosis is a Non-moving 
bacillus that lacks spore and acid fast. This 
bacterium produces a unique compound called 
mycolic acid in its wall affecting the performance 
of the wall (1). The vascular wall of this bacterium 
offers unique properties such as hydrophobicity, 
having acid fast, acid resistance, openness, dryness 
and many antibiotics. The bacterial growth is very 
slow and the cell division time is between 12 and 
24 hours (2). The slow growth has to do with the 
impermeability of cellular wall that makes the 
absorption of foodstuffs very slow. Moreover, the 
extent of RNA synthesis is slow as well. In the 
past, it was assumed that mycobacterium 
tuberculosis was formed from mycobacterium 
bovis during the domestication of livestock (3). The 
genome sequencing of both bacteria indicate that 
mycobacterium bovis has some deletions in its 
genome but it is 99.95% similar to the DNA of 
mycobacterium tuberculosis. This finding negates 
the formation of mycobacterium tuberculosis from 
mycobacterium bovis (4). Mycobacterium 
tuberculosis was identified as the cause of 
tuberculosis by Robert Koch in 1882. 
Mycobacterium tuberculosis, the causative agent of 
tuberculosis, is considered as a serious global 
health problem all specially in underdeveloped as 
well as developing countries (5). John Bunyan has 
named tuberculosis as the captain of human death, 
and Olivier Wendell Holmes has called 
tuberculosis the white plague. This disease has 
continued to be a serious threat for human health. 
 
METHODOLOGY: 
In this review article, the databases Medline, 
Cochrane, Science Direct, and Google Scholar 
were thoroughly searched to identify the studies 
investigating Tuberculosis and BCG vaccine. In 
this review, the papers published until early 
January 2017 that were conducted to study the 
Tuberculosis and BCG vaccine were selected. In 
searching for the articles,  those English papers 
were selected that had investigated Tuberculosis 
and BCG vaccine and it's complications. 
 
FINDINGS: 
FSC vaccine has been used all over the world since 
1921. This vaccine is made from the organism of 
mycobacterium bovis. The protective effect of this 
vaccine is generally considered 40-60%. The 
protection against milliard TB and Tuberculous 
meningitis is estimated to be 80-90% (6). FSC 
vaccine is inoculated at birth in many countries. Its 
inoculation dose is 5.0 ml in children under one 
year old. It is injected intradermally at the deltoid 
region of the right arm. BCG vaccine is one of the 
safest vaccines and has few dangerous 
complications (7). However, the tuberculosis 
arising from its inoculation, despite being rare and 
having the prevalence of less than one case in one 
case of inoculated dose, has a high rate of mortality 
and is considered as the most dangerous 
complication of vaccine (8). That is why this 
vaccine is inoculated at birth in most of the 
countries. The awareness of this dangerous 
complication, its underlying causes, and the clinical 
features of this disease, and paying due attention to 
this complication while examining infants who are 
taken to the doctor for the magnitude of lymph 
nodes adjacent to the inoculation region is of great 
importance for all doctors specially pediatricians 
(9).  
 
DISCUSSION AND CONCLUSION: 
The most important part of the controversial 
discussion of BCG vaccine is about its different 
efficacy (10). In a study conducted in Britain, the 
immunity of BCG vaccine was estimated to be 60-
80%. However another study reported that this 
vaccine lacks any efficacy (11). The study 
conducted by Fine et al indicated that BCG is likely 
to reduce TB infection rate up to 50%. Moreover, 
the aforementioned study indicated that BCG 
vaccine is able to reduce the infection to 19-27% 
and reduce the likelihood of the disease progress to 
an active form up to 71% (12). The studies indicate 
that the efficacy of the vaccine reaches zero after 
20 years of immunization. However, a study 
showed evidences of the vaccine efficacy after 60 
years of primary immunization (13). BCG vaccine 
is highly effective in the prevention of miliary 
tuberculosis and meningitis. Thus, even when the 
efficacy of the vaccine for immunizing against 
pulmonary tuberculosis is not effective, the vaccine 
is still prescribed for fighting against miliary 
tuberculosis and meningitis(14). Using BCG as a 
post-infection vaccine against tuberculosis does not 
create sufficient immunity against the recurrence of 
the infection in adults and makes the infection even 
worse (15). The worsening of the disease by BCG 
vaccine was observed after the primary infection 
with TB bacillus in the animal model and this can 
be one of the reasons why BCG vaccination failed 
in the endemic areas (16). In the endemic where the 
individuals are highly exposed to bacteria, BCG 
revaccination results in active tuberculosis.    
For this reason, the doctors need to be aware of the 
dangerous, yet less prevalent, complications of 
BCG vaccine. When they are examining the 
infants, they need to conduct complete examination 
and examine cervical and adjacent lymph node 
(17). They should also give due attention to 
hepatosplenomegaly, since when there are cases of 
hepatosplenomegaly, the patient needs to undergo 
further examination for the BCG infection. 
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